(September 4, 2008) Paul Norman, DS, FRACS, discusses several different types of biomarkers, both chemical and genetic, and the need for greater instances of replication and screening to find more conclusive evidence for therapeutic methods.
2008 Stanford AAA Summit
http://vascular.stanford.edu/news/summit.html
Stanford School of Medicine
http://med.stanford.edu/
Stanford Channel on YouTube:
http://www.youtube.com/stanford
I cannot agree more.
thetricon69 3 months ago